Rarely does India Inc wake up and decide to go shopping abroad with conviction. So, when Sun Pharma acquired New Jersey-based pharma major Organon for $11.75 bn, in a deal expected to close in early 2027, it feels more like a declaration rather than a transaction.
For years, Indian companies have flirted with the idea of becoming global MNCs. They have opened offices abroad, hired consultants with reassuring accents, and printed 'global footprint' on annual reports. But true globalisation is not achieved through airport lounges and LinkedIn updates. It's achieved through ownership of assets, brands, markets - and, sometimes, challenges in unfamiliar time zones.
Acquisitions are certainly a way into relevance. When Tata Group acquired Jaguar Land Rover (JLR) in 2008, it wasn't just buying a struggling car business, but also a brand, engineering capability and a seat at the global automotive table. When Hindalco picked up Novelis in 2007, it became one of the world's largest aluminium players. These were not incremental moves but geopolitical statements disguised as M&A.
Globally, the playbook is even clearer. Microsoft didn't become a cloud powerhouse by meditating on its core values. It bought its way with deals like LinkedIn and GitHub. Disney didn't rely on Mickey Mouse alone. It acquired Marvel Studios, Lucasfilm and 21st Century Fox to build a content empire. Global giants don't wait to become great. They acquire greatness, then optimise it.
India Inc has traditionally approached acquisitions the way we approach buffet dinners: cautiously, with a small plate, and a lingering suspicion that something might go wrong. The result has been a series of tentative, often defensive, deals rather than bold, strategic bets.
Which is why moves like Sun's acquisition of Organon matter. They signal a shift from opportunistic buying to deliberate empire-building. And if India Inc is serious about becoming truly global, it needs to turn this into a habit, not a headline.
India Inc has had its share of post-acquisition indigestion. Cultural mismatches, integration failures, overpayment, and occasional discovery that the 'strategic asset' came with strategic liabilities. Buying a global company is easy. Running it without breaking it is the real test. So, what separates successful acquirers from enthusiastic collectors?
Clarity of intent Best acquisitions are driven by a clear strategic gap - technology, market access, brand or capability. When Facebook acquired Instagram and WhatsApp, it was securing its future in a mobile-first world.
Respect for what you've bought A success factor of the Tata-JLR story was restraint. Tata didn't rush in to 'Indianise' a British luxury brand. It provided capital, stability and patience - three things more valuable than synergy presentations.
Integration discipline Systems need to talk to each other. Cultures need to coexist without passive-aggressive communication. Leadership needs to align on what success looks like. None of this is glamorous, which is precisely why it's often neglected.
Financial courage + discipline Global acquisitions require boldness, not recklessness. Overpaying for an asset in the name of ambition is a time-honoured tradition across markets. The difference between vision and vanity is usually visible in the balance sheet 2 yrs later.
Long-term mindset Acquisitions are beyond QSQT (quarter-se-quarter-tak). They're decade-long commitments. Benefits - market share, brand equity, capability - compound over time. So do the mistakes.
For India Inc, the opportunity is enormous. The global economy is wobbling through yet another 'strategic reset', with companies in developed markets busy shedding non-core assets, and discovering joys of slower growth. For those willing to act, this is a buyer's market in formal attire. Indian companies, armed with cost discipline, operational efficiency and balance sheets that have recently discovered protein, are perfectly placed to step in.
This isn't just about corporate ambition. It's also about national positioning. Countries that produce MNCs shape global markets, influence supply chains, set standards, rewrite rules. If India wants to be more than a large domestic market, it needs companies that think - and act - globally.
Which brings us back to Sun Pharma. Deals like these are not just transactions but also signals that Indian companies are willing to step onto a larger stage, take on greater complexity, and accept that global leadership comes with global headaches.
One bold acquisition is a story. A series of them, executed well, becomes a strategy.
